Related Experiment Video
Updated: Nov 27, 2025
10:39
3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache
Published on: June 2, 2014
18.5K
Headache as a Prognostic Factor for COVID-19. Time to Re-evaluate
Paolo Martelletti1,2, Enrico Bentivegna2, Michelangelo Luciani2
1Department of Clinical and Molecular Medicine, Sapienza University, Rome, Italy.
SN Comprehensive Clinical Medicine
|December 2, 2020
Summary
Headache is an uncommon COVID-19 symptom, affecting only 13% of patients. Further research is needed to determine if headache predicts COVID-19 severity or loss of smell/taste, considering potential drug interactions.
Area of Science:
- Neurology
- Infectious Diseases
- Pharmacology
Background:
- Headache presents in a minority of patients with COVID-19.
- The prognostic value of headache in COVID-19 is not well-established.
- Potential links between headache, COVID-19 severity, and sensory dysfunctions require investigation.
Purpose of the Study:
- To evaluate headache as a potential prognostic factor in COVID-19.
- To explore the relationship between headache, olfactory/gustatory dysfunction, and COVID-19 severity.
- To analyze drug-drug interactions relevant to COVID-19 symptom management.
Main Methods:
- Epidemiological data collection from COVID-19 patients.
- Pathophysiological investigations into headache mechanisms in COVID-19.
- Comparative analysis of drug-drug interactions (DDIs).
Main Results:
- Headache observed in approximately 13% of presenting COVID-19 cases.
- Hypothesis regarding headache as a prognostic factor requires further validation.
- Need for robust data on sensory dysfunctions and DDIs.
Conclusions:
- Headache is not a predominant symptom in COVID-19.
- More research is essential to understand the role of headache in COVID-19 prognosis.
- Investigating sensory changes and DDIs is crucial for comprehensive COVID-19 patient care.
Related Concept Videos
01:30Stress and Mental Health
358
Chronic stress profoundly affects mental health, significantly influencing mood, behavior, and overall quality of life. Research closely links chronic stress with mental health conditions such as depression, anxiety, and substance use disorders. Ongoing exposure to stress can lead to physiological and psychological changes, initiating a cycle of emotional distress and maladaptive coping mechanisms.
Individuals with depression often experience challenges in both their personal and professional...
Individuals with depression often experience challenges in both their personal and professional...
358
01:27Psychoneuroimmunology: Cardiovascular Disease
198
Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
A key area of focus in PNI is the relationship between stress and coronary...
198
01:19Psychoneuroimmunology: Diabetes and Cancer
183
Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
183